GPER1 and gastric neoplasm: Specifically, it has been recently shown that GPER1 knockdown or antagonism enhances the sensitivity of gastric cancer cells to Cp, suggesting that GPER1 can be a target to improve Cp chemotherapeutic efficacy against gastric tumors developing chemoresistance [69].